Bloomberg Business of Sports lets you follow the money in the world of sports, reporting on trades, salaries, endorsements, contracts and collective bargaining. The show takes listeners inside the business end of the sports world, and explains what it means to fans and their pocketbooks.
Ashlee Vance explores innovations in new tech, software, engineering, and science in places outside of Silicon Valley.
Iraq, US Talks Lead to ‘Substantial’ Iran Gas Dues Arrangements
Credit Suisse CEO Memo Signals UBS Deal to Close Monday
Fed Is First to Reach Crucial Junction in Global Inflation Fight
SNB’s Jordan Puts Switzerland’s Neutral Interest Rate Around 2%
Ukraine Economy Contracts Less Than Expected Despite Attacks
Man City Seeks First Champions League Title; Inter Milan Eyes Upset
Sunak Hints at UK Crackdown on Airline-Style ‘Drip Pricing’
GameStop Needs Ryan Cohen More Than Ever to Maintain Meme Status
OpenAI’s CEO Calls on China to Help Shape AI Safety Guidelines
Macron Polishes France’s AI Agenda in Meeting With Meta, Google
Trudeau Pledges New Military Aid to Ukraine During Surprise Trip
Trump’s Die-Hard Base Faces New Loyalty Test Over Indictment
Why Billionaires Are Circling Debt-Laden French Grocer Casino
US Housing Market Is Missing 320,000 Affordable Homes
A Peek Inside the VIP Speakeasy Lounge at the 2023 Tony Awards
Boris Johnson, the Once and Perhaps Future Tory King
Messi to Miami? It’s Not as Crazy as It Looks
New York’s Big Smoke Should Give Stovetop Warriors Pause
The Netflix Effect Chills Foreign Content Creators
Payrolls, Prices, Productivity and Profits Hold the Answer to the Puzzling US Economy
Will Argentina Ditch the Peso for the Dollar?
Sunak Urged to Publish UK Report on Abuse of LGBTQ Soldiers
Dimon Sought for Fresh Deposition in JPMorgan Epstein Suit
Ukraine Warns of Toxic Black Sea ‘Garbage Dump’ From Dam Debris
New York and East Coast Get Reprieve From Smoke as Skies Clear
A Sherbet-Colored Experiment in Cohousing Outside of Boston
NYC Pays Over $300 a Night for Budget Hotel Rooms for Migrants
Connecticut May Ban Collection Tactic Used in Cash-Advance Loans
Nigeria’s SEC Says Binance Operations in Country Are ‘Illegal’
Robinhood Removes 3 Crypto Tokens Following Regulatory Crackdown
Coinbase Suit May Finally Send Crypto Debate to US Supreme Court
Mifepristone now accounts for 54% of all pregnancy terminations in the U.S., despite efforts by many states to restrict access.
For decades the fight to end abortion in America has been waged over Roe v. Wade. With the Supreme Court poised to overturn the landmark decision that legalized a woman’s right to choose, the fight to stop abortion is going to become a fight about a pill.
Mifepristone, originally known as RU-486, was approved in the U.S. in 2000 after being on the market overseas for more than a decade. When used in combination with another drug, misoprostol, it’s more than 95% effective in terminating a pregnancy within the first 10 weeks. Data overwhelmingly show it’s safe. Yet, as I wrote in a Bloomberg Businessweek cover story earlier this year, it’s regulated like almost no other drug in the U.S. The federal government has one set of restrictions on how the pill is used, and state governments have additional, often more onerous rules.